セルベースアッセイ市場規模、シェア、成長分析：製品別、技術別、用途別、エンドユーザー別、地域別 - 産業予測 2025～2032年

セルベースアッセイの世界市場規模は、2023年に172億米ドルと評価され、2024年の184億6,000万米ドルから2032年には324億3,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは7.3％で成長する見通しです。

COVID-19パンデミックは世界の研究状況に大きな影響を与え、感染を検出するための効率的な手法の急速な採用と研究開発を促しました。注目すべきは、T-Detect COVID-19 T細胞検査のような検査がFDAの緊急使用認可を得たことで、診断学の革新が示されたことです。感染症、がん、自己免疫疾患、遺伝子異常の増加により、バイオテクノロジー研究の必要性とともに創薬の需要が高まるにつれ、市場は大きく成長する見込みです。細胞ベースの薬剤スクリーニングアッセイは、実行可能な薬剤候補を選択し、リード化合物のプロファイリング、細胞シグナル伝達解析、毒性評価を可能にするために極めて重要です。アネキシンV-Cy3アポトーシス検出キットはその一例であり、治療法の研究開発を推進する上で、これらのアッセイの多用途性と重要性を浮き彫りにしています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 技術分析
• 特許分析
• ケーススタディ

セルベースアッセイ市場規模：提供別& CAGR（2025-2032）

• 市場概要
• 消耗品
  • 試薬
  • アッセイキット
  • レポーター遺伝子アッセイ
  • 細胞増殖アッセイ
  • 二次メッセンジャーアッセイ
  • 細胞死アッセイ
  • その他のアッセイキット
  • マイクロプレート
  • 細胞株
  • 不死化細胞株
  • 一次細胞株
  • 幹細胞株
  • プローブとラベル
  • その他の消耗品
• 機器
• サービス
• ソフトウェア

セルベースアッセイ市場規模：技術別& CAGR（2025-2032）

• 市場概要
• フローサイトメトリー
• ハイスループットスクリーニング
• ラベルフリー検出
• その他の技術

セルベースアッセイ市場規模：用途別& CAGR（2025-2032）

• 市場概要
• 創薬
  • 毒性研究
  • 薬物動態研究
  • 薬力学的研究
• 基礎調査
• 遺伝学研究
• その他の用途

セルベースアッセイ市場規模：エンドユーザー別& CAGR（2025-2032）

• 市場概要
• 製薬・バイオテクノロジー企業
• 契約調査機関
• 学術調査機関

セルベースアッセイ市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Thermo Fisher Scientific, Inc.（United States）
• Promega Corporation（United States）
• Merck KGaA（Germany）
• PerkinElmer, Inc.（United States）
• Danaher Corporation（United States）
• Cell Signaling Technology, Inc.（United States）
• Bio-Rad Laboratories, Inc.（United States）
• Agilent Technologies, Inc.（United States）
• GE Healthcare（United Kingdom）
• Lonza Group Ltd.（Switzerland）

結論と提言

Global Cell-Based Assays Market size was valued at USD 17.2 billion in 2023 and is poised to grow from USD 18.46 billion in 2024 to USD 32.43 billion by 2032, growing at a CAGR of 7.3% during the forecast period (2025-2032).

The COVID-19 pandemic significantly impacted the global research landscape, prompting rapid adoption of efficient methodologies and the development of cell-based assays to detect infections. Notably, tests like the T-Detect COVID-19 T-cell test gained FDA Emergency Use Authorization, illustrating the innovation in diagnostics. As drug discovery demands rise alongside the need for biotechnology research due to increasing rates of infectious diseases, cancer, autoimmune disorders, and genetic anomalies, the market is positioned for substantial growth. Cell-based drug screening assays are crucial for selecting viable drug candidates, enabling lead profiling, cellular signaling analysis, and toxicity assessments. An example is the Annexin V-Cy3 apoptosis detection kit, highlighting the versatility and importance of these assays in advancing therapeutic research and development.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cell-Based Assays market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cell-Based Assays Market Segments Analysis

Global Cell-Based Assays Market is segmented by Offering, Technology, Application, End User and region. Based on Offering, the market is segmented into Consumables, Instruments, Services and Software. Based on Technology, the market is segmented into Flow Cytometry, High-Throughput Screening, Label-Free Detection and Other Technologies. Based on Application, the market is segmented into Drug Discovery, Basic Research, Genetic Studies and Other Applications. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Academic & Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cell-Based Assays Market

The rising incidence of chronic illnesses, including cancer, cardiovascular conditions, and neurodegenerative diseases, significantly drives the demand for sophisticated cell-based assays utilized in disease modeling and pharmaceutical testing. As healthcare professionals and researchers seek to innovate treatments and understand the complexities of these ailments, advanced assays become essential tools in their arsenal. These methodologies not only enhance the efficiency of drug development processes but also pave the way for more precise modeling of disease mechanisms. Consequently, this growing need for effective assessment techniques in the medical field is a major driver in the global cell-based assays market.

Restraints in the Global Cell-Based Assays Market

The Global Cell-Based Assays market faces significant restraints due to the resource-intensive nature of developing and conducting these assays. The associated costs for reagents, specialized equipment, and the need for skilled personnel can create substantial barriers, especially for smaller research organizations lacking the necessary financial and technical resources. This situation can hinder their ability to compete effectively in the market, limiting innovation and development opportunities. As a result, these factors may restrict the growth and accessibility of cell-based assays, potentially impacting the overall market dynamics and slowing advancements in related research fields.

Market Trends of the Global Cell-Based Assays Market

The Global Cell-Based Assays market is experiencing a notable trend towards the adoption of 3D cell culture models, driven by their enhanced ability to mimic in vivo physiological conditions. This transition is fostering more accurate drug screening and toxicity assessment, thereby increasing the effectiveness of preclinical testing. As research continues to emphasize the importance of biologically relevant platforms, the demand for advanced 3D cell culture technologies is likely to surge. This market shift reflects a broader commitment to improving drug development processes and ensuring better therapeutic outcomes, positioning 3D cell culture as a pivotal innovation in cell-based assay methodologies.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Analysis
• Patent Analysis
• Case Studies
• Global Cell-Based Assays Market Size by Offering & CAGR (2025-2032)
• Market Overview
• Consumables
  • Reagents
  • Assay Kits
  • Reporter gene assays
  • Cell growth assays
  • Secondary messenger assays
  • Cell death assays
  • Other assay kits
  • Microplates
  • Cell Lines
  • Immortalized cell lines
  • Primary cell lines
  • Stem cell lines
  • Probes & Labels
  • Other Consumables
• Instruments
• Services
• Software

Global Cell-Based Assays Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Flow Cytometry
• High-Throughput Screening
• Label-Free Detection
• Other Technologies

Global Cell-Based Assays Market Size by Application & CAGR (2025-2032)

• Market Overview
• Drug Discovery
  • Toxicity Studies
  • Pharmacokinetic Studies
  • Pharmacodynamic Studies
• Basic Research
• Genetic Studies
• Other Applications

Global Cell-Based Assays Market Size by End User & CAGR (2025-2032)

• Market Overview
• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations
• Academic & Research Institutes

Global Cell-Based Assays Market Size & CAGR (2025-2032)

• North America (Offering, Technology, Application, End User)
  • US
  • Canada
• Europe (Offering, Technology, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Offering, Technology, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Offering, Technology, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Offering, Technology, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cell Signaling Technology, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations